Interaction of morphine tolerance with pentylenetetrazole-induced seizure threshold in mice: The role of NMDA-receptor/NO pathway.

Abstract

N-methyl-d-aspartate receptor (NMDA-R)/nitric oxide (NO) pathway is involved in the intensification of the analgesic effect of opioids and the reduction of the intensity of opioids tolerance and dependence. In the current study, we investigated the involvement of NMDA-R/NO pathway in chronic morphine-treated mice in both the development of tolerance to the analgesic effect of morphine and in pentylenetetrazole (PTZ)-induced seizure threshold. Chronic treatment with morphine (30 mg/kg) exhibited increased seizure resistance in morphine-induced tolerant mice. The development of morphine tolerance was withdrawn when used concomitantly with NOS inhibitors and NMDA-R antagonist, suggesting that the development of tolerance to the anticonvulsant effect of morphine (30 mg/kg) is mediated through the NMDA-R/NO pathway. A dose-dependent biphasic seizure modulation of morphine was demonstrated in the acute treatment with morphine; acute treatment at a dose of 0.5 mg/kg shows the anticonvulsant effect and at a dose of 30 mg/kg shows proconvulsant effect. However, a different pattern was observed in the mice treated chronically with morphine: they demonstrated tolerance in the tail-flick test; five consecutive days of chronic treatment with a high dose of morphine (30 mg/kg) showed anticonvulsant effect while a low dose of morphine (0.5 mg/kg) showed a proconvulsant effect. The anticonvulsant effect of morphine was inhibited completely by the concomitant administration of NO synthase (NOS) inhibitors including nonspecific NOS inhibitor (L-NAME, 10 mg/kg), inducible NOS inhibitor (aminoguanidine, 50 mg/kg), and neuronal NOS inhibitor (7-nitroindazole (7-NI), 15 mg/kg) for five consecutive days. Besides, five days injection of NMDA-R antagonist (MK-801, 0.05 mg/kg) significantly inhibited the anticonvulsant effect of morphine on the PTZ-induced clonic seizures. The results revealed that chronic treatment with morphine leads to the development of tolerance in mice, which in turn may cause an anticonvulsant effect in a high dose of morphine via the NMDA-R/NO pathway.

• Authors: Golnaz Zamanian, Maryam Shayan, Nastaran Rahimi, Taraneh Bahremand, Hamed Shafaroodi, Shahram Ejtemaei-Mehr, Iraj Aghaei, Ahmad Reza Dehpour
• Journal: Epilepsy & behavior : E&B (Epilepsy Behav) Vol. 112 Pg. 107343 (11 2020) ISSN: 1525-5069 [Electronic] United States
• PMID: 32755816 (Publication Type: Journal Article)
• Copyright: Copyright © 2020 Elsevier Inc. All rights reserved.

Chemical References

• Anticonvulsants
• Receptors, N-Methyl-D-Aspartate
• Nitric Oxide
• N-Methylaspartate
• Morphine
• NG-Nitroarginine Methyl Ester
• Pentylenetetrazole

Topics

• Animals
• Anticonvulsants (therapeutic use)
• Dose-Response Relationship, Drug
• Mice
• Morphine (therapeutic use)
• N-Methylaspartate (therapeutic use, toxicity)
• NG-Nitroarginine Methyl Ester
• Nitric Oxide (metabolism)
• Pentylenetetrazole (toxicity)
• Receptors, N-Methyl-D-Aspartate
• Seizures (chemically induced, drug therapy)